Kevin S. Sr. Boyle - Mar 15, 2023 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Chief Executive Officer, Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Mar 15, 2023
Transactions value $
$0
Form type
4
Date filed
3/17/2023, 08:30 PM
Previous filing
Sep 1, 2022
Next filing
Sep 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +1.8M $0.00 1.8M Mar 15, 2023 Common Stock 1.8M $0.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from January 1, 2023, with the first vesting occuring on April 1, 2023, subject to the Reporting Person's continued service through each such date.